A case of rhabdomyolysis with fatal outcome after a treatment with levofloxacin

Fluoroquinolones are known to cause rhabdomyolysis. Levofloxacin is a recent fluoroquinolone and its muscular toxicity is not well documented. We describe the case of a 77-year-old female patient, who presented with an acute rhabdomyolysis after treatment with levofloxacin. She had a background of s...

Full description

Saved in:
Bibliographic Details
Published in:European journal of clinical pharmacology 2003-12, Vol.59 (10), p.779-780
Main Authors: PETITJEANS, Fabrice, NADAUD, Julien, PEREZ, Jean Paul, DEBIEN, Bruno, OLIVE, Frederic, VILLEVIEILLE, Thierry, PATS, Bruno
Format: Article
Language:English
Subjects:
Aged
Anti-Infective Agents - adverse effects
Biological and medical sciences
Drug toxicity and drugs side effects treatment
Fatal Outcome
Female
Humans
Levofloxacin
Medical sciences
Ofloxacin - adverse effects
Pharmacology. Drug treatments
Rhabdomyolysis - chemically induced
Toxicity: nervous system and muscle
Citations: Items that cite this one
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
Summary:Fluoroquinolones are known to cause rhabdomyolysis. Levofloxacin is a recent fluoroquinolone and its muscular toxicity is not well documented. We describe the case of a 77-year-old female patient, who presented with an acute rhabdomyolysis after treatment with levofloxacin. She had a background of serious cardio-pulmonary disease. She received an oral ambulatory treatment with levofloxacin for pulmonary infection. After 6 days, she presented with severe rhabdomyolysis, resulting in complete anuria with hyperkalaemia, complicated with acute liver cytolysis and respiratory failure. The treatment was a daily repeated haemodialysis. She presented with a fatal myocardial infarction 13 days after admission. The medical history inclines us to strongly suspect levofloxacin as the cause of this severe adverse drug reaction. We also reviewed 27 other suspect cases reported in the database provided by the World Health Organization Collaborating Centre for Drug Monitoring (Uppsala, Sweden). We conclude that rhabdomyolysis can be a rare, severe adverse effect of levofloxacin, as well as the other fluoroquinolones.
ISSN:0031-6970
1432-1041
DOI:10.1007/s00228-003-0688-x